COVERSIN
COVERSIN Uses, Dosage, Side Effects, Food Interaction and all others data.
COVERSIN is under investigation in clinical trial NCT03427060 (Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms).
| Trade Name | COVERSIN |
| Generic | Nomacopan |
| Nomacopan Other Names | COVERSIN, Nomacopan |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here COVERSIN
